Hbk Investments L P Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Hbk Investments L P

  • $5.14 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$12.64 - $24.5 $44.9 Million - $87 Million
-3,550,000 Closed
0 $0
Q3 2022

Aug 14, 2023
BUY
$144.95 - $152.29 $395 Million - $415 Million
2,725,000 Added 330.3%
3,550,000 $537 Million
Q2 2022

Aug 14, 2023
BUY
$83.14 - $145.99 $68.6 Million - $120 Million
825,000 New
825,000 $120 Million
Q2 2019

Aug 14, 2019
BUY
$39.79 - $67.01 $3.18 Million - $5.36 Million
80,000 New
80,000 $3.5 Million

Others Institutions Holding BHVN

# of Institutions
11
Shares Held
792K
Call Options Held
0
Put Options Held
0
View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

BHVN Quotes by TradingView
  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $3.27B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Hbk Investments L P Portfolio

Follow Hbk Investments L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

News

Stay updated on Hbk Investments L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email